In a major step towards integrating patient and clinician perspectives into mental health technology, the TRUSTING project is proud to announce that its Clinical User Board (TRUSB-C) is nearing completion. This board, coordinated by the European Psychiatric Association (EPA), will bring together 10 leading experts in psychosis treatment from across Europe, all working towards the development of an AI-driven monitoring tool to detect early signs of psychotic relapse.
The TRUSTING project aims to develop a user-friendly and trustworthy AI application for home use. The tool’s primary function will be to analyse speech patterns that may indicate the onset of a psychotic episode, enabling timely intervention and support. To ensure the application meets the needs of its users, the project created the TRUSTING Users Board (TRUSB), which brings together both clinicians and patients in a collaborative effort.
The TRUSTING Users Board is divided into two subgroups: the Clinical User Board (TRUSB-C) for clinicians and the Patients User Board (TRUSB-P) for individuals with lived experience of psychosis. The patients’ board is coordinated by GAMIAN-Europe, and both subgroups will work closely to ensure that the AI tool reflects both medical expertise and the real-world experiences of those living with psychosis. Together, these two boards will form the foundation of the TRUSB, which is critical to ensuring that the tool is not only effective but also aligned with the actual needs and concerns of future users.
This collaborative effort is a direct response to the growing recognition of the role both patients and clinicians play in shaping healthcare innovations. The European Union, in particular, has emphasised patient involvement in health research, making it a key criterion for project funding. The TRUSTING project embodies this approach, recognising that technological advancements are most successful when developed in partnership with those they aim to serve.
The EPA is excited to contribute to this unique exchange of perspectives, as it strengthens the trustworthiness of the tool while enhancing patient empowerment in healthcare. Both the clinical and patient boards will also contribute to other key aspects of the project, including designing a Randomised Clinical Trial (RCT), strategic communications, and an educational course aimed at empowering users.
As the project moves forward, the TRUSTING Users Board will play a crucial role in ensuring that the AI tool being developed is not only cutting-edge but also resonant with the needs of its users. This initiative will bridge the gap between technological innovation and practical application, shaping the future of mental health care in Europe.
Stay updated on the TRUSTING project’s progress and its potential to transform mental health care or to engage with our communications, visit our website or follow us on social media platforms, including X and LinkedIn. We also encourage you to join our database by subscribing to our e-newsletter here.
